Abooshahab R, Al-Salami H, Dass CR. Targeting metabolic vulnerabilities in breast cancer cells by combining PEDF and doxorubicin: pathway insights from GC/MS-based metabolomics. EXCLI J. [Internet]. 2025 Aug. 18 [cited 2025 Dec. 7];24:1037-55. Available from: https://www.excli.de/excli/article/view/8508